Thank you very much for being part of the GRK 2162!


Prof. Kristina Friedland

Department of Chemistry and Pharmacy
Professorship of Molecular and Clinical Pharmacy


2005 PhD in Pharmacology, Goethe University Frankfurt

2005 Postdoctoral Fellow, Pharmacology, Goethe University Frankfurt and Department of Neurobiology, University of Alabama, Birmingham/USA

2011 Professor, FAU Erlangen-Nürnberg

2017 Professor, Pharmacology & Toxicology, Johannes Gutenberg University Mainz

Research focus

Research in my group aims to understand the pathophysiology of neuropsychiatric diseases e.g. mood disorders and Alzheimer disease with a focus on ion channels and mitochondria. In addition, we aim to develop new pharmacological therapies for these diseases.


Interaction of ASM/ceramide system and TRPC6 channels and its role in plasticity and depression-like behavior

1999 MD, University of Freiburg (Breisgau)

2007 Specialization in Neurology at the University Hospitals in Würzburg, Göttingen and Bochum

2008 Head of the Neuroimmunology Laboratory, Department of Neurology, FAU Erlangen-Nürnberg

2010 Head of the Neuroimmunology Section, Department of Neurology, FAU Erlangen-Nürnberg

2013 Professor for Neuroimmunology, FAU Erlangen-Nürnberg

2018 Chair of Neurology, University Hospital Regensburg

Research focus

My continuing scientific interests include neurodegeneration and neuroprotection as well as glial cells in MS, and mechanisms of action of new immunotherapies.


Role of the transcription factors Sox8 and Sox10 in susceptibility and repair in demyelinating diseases

PD Dr. Hanna Regus-Leidig

Research Fellow

Department of Biology
Chair of Animal Physiology

2008 PhD, Max Planck Institute for Brain Research, Frankfurt/Main, and FAU Erlangen-Nürnberg

2008 University Assistant, Department of Biology, FAU Erlangen-Nürnberg

2014 Habilitation in Zoology, FAU Erlangen-Nürnberg

2014 Group Leader, Department of Biology, FAU Erlangen-Nürnberg

2018 HTA Writing Expert, Novartis, Nürnberg

Former research focus

The research of the Brandstätter and Regus-Leidig group focuses on molecules and mechanisms that play a role in the development and the structural and functional organization of chemical synapses in the CNS with a special focus on the retina. In our experimental approach, we combine methods ranging from immunocytochemistry and light- and electron microscopical imaging to biochemistry, cell and molecular biology, and electrophysiology.

As synaptophathies = malfunctioning synapses are a reason for many neurodegenerative diseases and neurological disorders, the aim of our research is to contribute to a better understanding of synapse function in health and disease.

Former project

Examining the synaptogenesis and synapse maintenance factor Bassoon as a putative factor for the differential sensitivity of photoreceptors to late-onset degeneration